Impact of TH and DCX mRNAs detection in high-risk neuroblastoma patients' outcome

被引：0
|
作者：
Canete, A. [1 ]
Yanez, Y. [1 ]
Grau, E. [1 ]
Palanca, S. [2 ]
Perez, G. [2 ]
Antuna, M. J. [3 ]
Marquez, C. [4 ]
Gallego, S. [5 ]
Urberuaga, A. [6 ]
Castel, V. [1 ]
机构：
[1] Hosp Univ & Politecn La Fe, Valencia, Spain
[2] Hosp Univ & Politecn La Fe, Mol Biol Lab, Valencia, Spain
[3] Hosp Univ Cent Asturias, Asturias, Spain
[4] Hosp Univ Virgen del Rocio, Seville, Spain
[5] Hosp Univ Vall dHebron, Barcelona, Spain
[6] Hosp Univ Cruces, Vizcaya, Spain
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1624
引用
收藏
页码：S356 / S357
页数：2
相关论文
共 50 条
  • [21] Treatment of High-Risk Neuroblastoma
    Sung, Kiwoong
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S3 - S3
  • [22] Telomere Maintenance Mechanisms Define Clinical Outcome in High-Risk Neuroblastoma
    Koneru, Balakrishna
    Lopez, Gonzalo
    Farooqi, Ahsan
    Conkrite, Karina L.
    Nguyen, Thinh H.
    Macha, Shawn J.
    Modi, Apexa
    Rokita, Jo Lynne
    Urias, Eduardo
    Hindle, Ashly
    Davidson, Heather
    Mccoy, Kristyn
    Nance, Jonas
    Yazdani, Vanda
    Irwin, Meredith S.
    Yang, Shengping
    Wheeler, David A.
    Maris, John M.
    Diskin, Sharon J.
    Reynolds, C. Patrick
    CANCER RESEARCH, 2020, 80 (12) : 2663 - 2675
  • [23] Treatment of High-Risk Neuroblastoma
    Krystal, Julie
    Foster, Jennifer H.
    CHILDREN-BASEL, 2023, 10 (08):
  • [24] Chemoimmunotherapy for high-risk neuroblastoma
    Kushner, Brian H.
    LANCET ONCOLOGY, 2017, 18 (07): : 845 - 846
  • [25] Induction for high-risk neuroblastoma
    Kushner, Brian H.
    Cheung, Nai-Kong V.
    PEDIATRIC BLOOD & CANCER, 2007, 49 (03) : 221 - 223
  • [26] The impact of wait times on oncological outcome in high-risk patients with endometrial cancer
    Mitric, Cristina
    Matanes, Emad
    Wissing, Michel
    Amajoud, Zainab
    Abitbol, Jeremie
    Yasmeen, Amber
    Lopez-Ozuna, Vanessa
    Eisenberg, Neta
    Laskov, Ido
    Lau, Susie
    Salvador, Shannon
    Gotlieb, Walter H.
    Kogan, Liron
    JOURNAL OF SURGICAL ONCOLOGY, 2020, 122 (02) : 306 - 314
  • [27] Genetic Alterations and Resectability Predict Outcome in Patients with Neuroblastoma Assigned to High-Risk Solely by MYCN Amplification
    Berthold, Frank
    Ernst, Angela
    Ackermann, Sandra
    Bartenhagen, Christoph
    Christiansen, Holger
    Hero, Barbara
    Rosswog, Carolina
    von Schweinitz, Dietrich
    Klingebiel, Thomas
    Schmid, Irene
    Simon, Thorsten
    Fischer, Matthias
    CANCERS, 2021, 13 (17)
  • [28] THE OUTCOME OF TREATMENT IN PATIENTS WITH HIGH-RISK RETINOBLASTOMA
    Poliakov, Vladimir
    Ushakova, Tatiana
    Dolgopolov, Igor
    Gorovtzova, Olga
    Matveeva, Irina
    Pavlovskaya, Alentina
    Glekov, Igor
    Osipova, Marina
    Bolotin, Michail
    Pimenov, Roman
    Boayrshinov, Vasily
    Mentkevich, Georgy
    PEDIATRIC BLOOD & CANCER, 2009, 53 (05) : 813 - 813
  • [29] Allogeneic transplantation for patients with high-risk or refractory neuroblastoma.
    Driscoll, T. A.
    Martin, P. L.
    Moffet, J.
    Daniel, M.
    Page, K.
    Parikh, S.
    Prasad, V.
    Szabolcs, P.
    Kurtzberg, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [30] Survival of high-risk pediatric neuroblastoma patients in a developing country
    Easton, Joseph C.
    Gomez, Sergio
    Asdahl, Peter H.
    Conner, J. Michael
    Fynn, Alcira B.
    Ruiz, Claudia
    Ojha, Rohit P.
    PEDIATRIC TRANSPLANTATION, 2016, 20 (06) : 825 - 830
12345